Phase II Trial of Paclitaxel and Cisplatin in Metastatic and Recurrent Carcinoma of the Uterine Cervix

Christos Papadimitriou; K. Sarris; Lia A. Moulopoulos; George Fountzilas; Athanassios Anagnostopoulos; Zannis Voulgaris; Dimitra Gika; Nikolaos Giannakoulis; Emmanuel Diakomanolis; Meletios A Dimopoulos

doi:10.1200/jco.1999.17.3.761

Abstract

1 min read

The combination of paclitaxel with cisplatin seems relatively well tolerated and moderately active in patients with metastatic or recurrent cervical cancer. The significant incidence of neurotoxicity is of concern, and alternative methods of administration of the two agents could be evaluated. Then, further study of this combination, alone or with the addition of other active agents, is warranted.

Related publications

Article2004

Pegylated liposomal doxorubicin hydrochloride (PLD) and paclitaxel in recurrent or metastatic head and neck carcinoma: a phase I/II study conducted by the Hellenic Cooperative Oncology Group (HeCOG)

Jim Janinis, George P. Stathopoulos, Paul Nikolaidis, Haralabos P. Kalofonos, Anna Kalogera‐Fountzila, E. Samantas, Gerasimos Aravantinos, Athanassios Anagnostopoulos, Christos Tolis, Thomas Makatsoris, S. Rigatos, Dimitrios Bafaloukos, Meletios A Dimopoulos, John Daniilidis, George Fountzilas

Article1997

A Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of metastatic carcinoma of the uterine cervix

Christos Papadimitriou, Meletios A Dimopoulos, Nikolaos Giannakoulis, K. Sarris, Georgios Vassilakopoulos, T. Akrivos, Zannis Voulgaris, Georgios Vlahos, E Diakomanolis, Stylianos Michalas

Article2000

Paclitaxel, cisplatin, and epirubicin first-line chemotherapy in Stage III and IV ovarian carcinoma

C.A. Papadimitriou, Lia A. Moulopoulos, Georgios Vlahos, Zannis Voulgaris, Evangelos Kiosses, Nikolaos Georgoulias, Dimitra Gika, Emmanuel Diakomanolis, Stylianos Michalas, Meletios A Dimopoulos

Article2022

Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial)

David Barnes, Peter H. Dutton, Øyvind S. Bruland, Hans Gelderblom, Ade Faleti, Claudia Bühnemann, Annemiek van Maldegem, Hannah Johnson, Lisa Poulton, Sharon Love, Gesa Tiemeier, Els van Beelen, Karin H. Herbschleb, Caroline Haddon, Lucinda Billingham, Kevin M. Bradley, Stefano Ferrari, Emanuela Palmerini, Piero Picci, Uta Dirksen, Sandra J. Strauss, Pancras C.W. Hogendoorn,

Article2001

Ifosfamide, paclitaxel and cisplatin first-line chemotherapy in advanced, suboptimally debulked epithelial ovarian cancer

Christos Papadimitriou, Charalambos Kouroussis, Lia A. Moulopoulos, Georgios Vlahos, Alexandros Rodolakis, Christos Kiamouris, Emmanuel Diakomanolis, Dimitra Gika, Stylianos Michalas, Meletios A Dimopoulos